Le Lézard
Classified in: Health
Subjects: AWD, NPT, CSR

Mainland China's first Carnegie Medal of Philanthropy recipient Mei Hing Chak brings Chinese philanthropy to the world stage


NEW YORK, Nov. 23, 2017 /PRNewswire/ -- The 2017 Carnegie Medal of Philanthropy awards ceremony was recently held in New York. The Carnegie institutions presented the Carnegie Medal of Philanthropy to nine philanthropists in recognition of their outstanding and innovative leadership in philanthropy. One of the honorees was Chairman of Heungkong Charitable Foundation, Mei Hing Chak, who became the first Carnegie Medal of Philanthropy recipient in mainland China and the second Chinese recipient following Li Ka-shing.

Prior to receiving the prestigious Carnegie Medal of Philanthropy, Mei Hing Chak and her husband Chi Keung Lau had created a legendary rags-to-riches business. Since forming the business more than 20 years ago, they have transformed Heungkong Group into a conglomerate that encompasses trade logistics, urban development, financial services, healthcare, education and tourism, as well as metals processing and energy. It has been ranked among China's Top 50 Private Companies.

Mei Hing Chak becomes mainland China's first Carnegie Medal of Philanthropy recipient

A voice of charity from China

The Carnegie Medal of Philanthropy was established by the Carnegie Foundation and is awarded every two years to individuals who share the same spirit of giving with founder Andrew Carnegie. As one of the world's most renowned philanthropy awards, the Carnegie Medal of Philanthropy is conducted in total secrecy, with neither the presenters nor the potential recipients of the award having any advance clue whatsoever as to whom the recipient might be. For this reason, Mei Hing Chak was astonished when she was informed that she was in fact a recipient.

Mei Hing Chak has been engaged in philanthropy for more than 20 years.

The 22 Carnegie institutions in the United States and Europe nominate the medalists, with seven among them proceeding into the final selection. The honorees are recognized as catalysts for good whose philanthropy has had a significant and lasting impact on a particular field, nation or community.

Dean of the Institute for Philanthropy at Tsinghua University, Wang Ming, said that Mei Hing Chak's winning of the medal is not only a personal honor, but also a testament to the vigorous development of modern public welfare in China, which has garnered a high level of international recognition.

Mei Hing Chak established China's very first private foundation

At the beginning of her career in philanthropy, Mei Hing Chak donated money to publicly funded charitable foundations, yet was frustrated by being unable to choose the projects that she felt were important and reflected her vision. In 1998, she decided to establish her own charitable foundation. However, at that time, China did not allow individuals or privately-run companies to found charitable foundations. In 2005, after the country loosened the restriction, Mei Hing Chak became the first to apply for the right to found a charitable foundation and received governmental approval. Heungkong Charitable Foundation's registration number for its status as a private foundation (referred to in China as a non-publicly funded charitable institution) is 001, reflecting the fact that it is China's very first.

Since its inception, Heungkong Charitable Foundation has been committed to carrying out educational assistance, poverty alleviation, aid and disaster relief throughout 18 provinces and cities including Guangdong, Guizhou and Sichuan. In 2007, the foundation launched the "Five 1000" program: building 1,000 libraries, helping 1,000 disadvantaged students, and leading 1,000 activities manned by volunteers. After years of expansion, Heungkong Charitable Foundation now has a team of nearly 20,000 volunteers, whose assistance in the aggregate has amounted to more than 100,000 instances of volunteer works being performed, benefiting more than 3 million individuals.

Precise positioning: help the disadvantaged through education and the provision of healthcare

Heungkong Charitable Foundation has been focused on helping the less fortunate through education as well as by providing aid and disaster relief. Following on a decade of experience, Mei Hing Chak is planning to give the foundation a more precise positioning whereby the focus is to be on helping the less fortunate through education and the provision of healthcare. In the educational sphere, the foundation will focus on two programs: building libraries and supporting disadvantaged college students. In the health sphere, Mei Hing Chak is planning to donate 1 billion yuan (approx. US$150 million) to charitable foundations dedicated to healthcare. Through the charitable foundations, the fund will be donated to specialized hospitals that will provide medical assistance in disadvantaged areas and to less fortunate people. Unlike traditional charity projects, this project can generate a cash flow for itself through the operation of the hospitals and, thereby, fund its further development.

Photo: https://mma.prnewswire.com/media/607621/Mei_Hing_Chak___Carnegie_Medal_of_Philanthropy_recipient.jpg


These press releases may also interest you

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...

at 07:00
César A. Lara, MD, introduces a groundbreaking solution for pain relief in the Tampa Bay area. Red Laser Therapy leverages the power of medical-grade red laser light to effectively address various types of pain, providing patients with a noninvasive...



News published on and distributed by: